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Abstract
Background: The transradial approach for percutaneous coronary intervention (PCI) seems
to be superior to transfemoral. The safety and efficacy of transradial approach for PCI in acute
myocardial infarction is not well-established.
Methods: Hundred patients with acute myocardial infarction qualified to PCI were randomly
assigned to transradial (group I; n = 50) and transfemoral (group II; n = 50) approaches.
Results: PCI was successful for almost all patients, except one from group II. There were no
significant differences between groups in X-ray exposition, volume of contrast and total proce-
dure duration. Small but significant elongation of door to stent time in group I was caused
mostly by a longer time between beginning of procedure and arterial sheath introduction.
Major bleeding complications occurred in three patients from group I and seven from group II.
There were no significant differences observed between the two groups. Time to ambulation in
group I was significantly shorter then in group II (22.6 ± 10.3 h vs. 34.7 ± 34.6 h; p = 0.003).
Conclusions: The transradial approach for PCI in acute myocardial infarction has the same
efficacy as transfemoral. There are no differences in total procedure duration, X-ray exposition
or volume of contrast between the two approaches. A longer time from the patient’s admission
to the individual stages of the PCI procedure in group I was mostly due to the longer times of
the initial stages of the procedure. The use of transradial approach reduces the time to ambula-
tion and allows rehabilitation to begin sooner. In both groups, bleeding complications occurred
rarely. (Cardiol J 2009; 16, 4: 332–340)
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Introduction
Heart catheterization using the radial artery
access site is a relatively new way of performing
coronary angiography (CA) and interventional pro-
cedures in patients with stable and unstable coro-
nary heart disease.
It was introduced to clinical practice in 1989 and
is employed in a limited number of centers [1–7].
Most centers performing CA examinations and
interventional procedures use the femoral artery ac-
cess site. The transradial approach (TRA) ensures
relatively high procedural effectiveness and a low
risk of local complications, and permits a quick mo-
bilization of the patient after the intervention [2, 8–
–12]. Furthermore, it decreases frequency of major
bleeding complications which may correlate with
lower mortality [13–17]. The vast majority of authors
discussing TRA for CA and percutaneous coronary
intervention (PCI) emphasize the relatively long
training period necessary for the effective and safe
performance of these procedures [11, 18, 19]. Interna-
tional literature provides some reports concerning the
TRA for PCI in patients with myocardial infarction (MI)
[12, 20–25]. The aim of our study was to compare the
usefulness, effectiveness and procedural course of the
TRA and transfemoral approaches (TFA) for PCI in
patients with ST-elevation MI (STEMI), as well as to
compare the effects during hospitalization.
Methods
The study protocol has been accepted by the
Bioethics Committee. Patients included in the study
fulfilled the following criteria:
— age between 18 and 75 years;
— presence of MI defined as retrosternal pain la-
sting longer than 20 minutes, but not longer
than 12 hours, resistant to nitroglycerin, and
accompanied by electrocardiography (ECG)
changes: ST elevation of at least 1 mV in two
neighboring leads or new left bundle branch
block, found in the qualifying ECG examination
performed in the admission room, in the refer-
ring hospital or in the emergency service;
— participation consent.
Criteria for exclusion were:
— age over 75 years;
— Killip class III or IV;
— necessity of an intra-aortic balloon pumping
placement before the CA;
— necessity of an endocavitary stimulating elec-
trode placement before the CA;
— height < 150 cm;
— history of coronary artery by pass grafting
(CABG), if the infarction may be due to a clo-
sed venous or arterial bypass graft.
The age exclusion criterion (age > 75 years)
is because substantially greater difficulties in ac-
cessing the radial artery can be expected
Qualification of patients
Our study included consecutive patients admit-
ted to the center where the authors work. The pa-
tients were divided into two groups according to the
treatment intention. Randomization was conduct-
ed in the admission room based on year of birth:
group I included individuals born in even years and
group II those born in odd years. All patients with
a MI who fulfilled the inclusion criteria were regis-
tered. The study included those who fulfilled the
inclusion criteria and did not fulfill the exclusion
criteria. Group I included patients in whom the
treatment intention was to perform heart catheter-
ization using the TRA. Group II included patients
in whom the treatment intention was to perform
heart catheterization using the TFA. CA was pre-
ceded by the radial artery compression test. A pulse
oximeter was used to establish an adequate collat-
eral blood flow from the ulnar artery. In the case of
an abnormal test result for the right upper limb, it
was repeated on the left one. If the result was nor-
mal, the CA was performed using the left TRA. If
the result was abnormal on both upper limbs, the
procedure was performed with the TFA. For femo-
ral artery puncturing, a 18 G needle and 0.035 inch
wire were used, while for radial artery puncturing
21 G and 0.021 inch wire was used. Vascular sheaths
size 6 F (Cordis, USA) were used for CA. For co-
ronarography, standard catheters 6 F type Judkins
and Amplatz (Asahi Intecc, Japan) were used. For
PCI the following were used: 6 F guiding catheters
Judkins, XB, Vista Brite Tip, JFL, JFR LBT (Cordis,
USA) and Judkins, EBU Laucher (Medtronic, USA);
guidewires Pilot 50,150 BMW (Guidant, USA); bal-
loon dilatation catheters: Voyager (Abbott, USA),
Maveric (Boston Scientific, USA), Crossale (Cordis,
USA); stents mainly Driver and Micro-Driver
(Medtronic, USA) and in some cases, Chopin (Bal-
ton, Poland). After puncturing the radial artery and
introducing the sheath, verapamil was administered
in the dose of 5 mg diluted in 5 mL of 0.9% NaCl.
The dose was repeated in the case of a spasm, until
reaching a total dose of 15 mg. Analgesia during the
procedure was achieved by administering morphine
in 2 mg doses, depending on the intensity of chest
pain. Activated clotting time was checked in all pa-
tients after introducing the vascular sheath. Depend-
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ing on activated clotting time result, additional doses
of heparin (70 U/kg) were administered. Fibrinolytic
drugs and platelet glycoprotein (GP) IIb/IIIa receptor
blockers were administered during the intervention
according to the operator’s decision. In patients from
group I, the vascular sheath was removed immediately
after the procedure, and the radial artery was secured
with a Terumo Band. Heparin administration was
continued after the intervention only in the presence
of clinical indications. Heart catheterization using TRA
has been performed in our center since August 2004.
The study was conducted by physicians with many
years’ experience of heart catheterization with TFA
(300–400 PCI per year), who had performed at least
50–100 interventions using TRA.
Definitions
Thrombosis in Myocardial Infarction (PCI) was
considered effective when a Thrombolysis In Myocar-
dial Infarction (TIMI) grade 3 flow rate was obtained
and residual stenosis was lower than 30%. Major bleed-
ing complications included: fatal bleeding, bleeding re-
quiring blood transfusion, operation or resulting in
a drop of haemoglobin count of more than 3 g/dL as
well as any intracranial haemorrhage. All other bleed-
ing complications were considered minor. Serious car-
diac events included a necessity of repeating the revas-
cularization procedure in the infarct-related artery (IRA),
a necessity of CABG, new MI occurrence and death from
any cause. Total procedure time was defined as the pe-
riod from the patient’s arrival in the Cath Lab to the re-
moval of the vascular sheath for group I, and to the re-
moval of the catheter from the sheath for group II.
Statistical analysis
The obtained numeric data were presented as
mean value ± standard deviation. Differences be-
tween the two groups were checked for significance
with the two-tailed Student’s t-test for independ-
ent variables, after checking the normality of data
distribution with the Kolmogorov-Smirnov test and
the equality of variances with the Fisher’s F-test.
Where the Student’s t-test could not be employed
(unequal variances, non-normal data distribution),
groups were compared using the Mann-Whitney U
test. Differences of relative frequencies were as-
sessed based on the relative frequencies test.
Results
Patients were recruited for the study during
the period April 2005 to June 2006. Of 181 consec-
utive patients with STEMI admitted to our center,
100 were included in the study (Fig. 1). Overall,
55% of STEMI patients were recruited for the
study. Table 1 presents the characteristics of inves-
tigated patients. There were no significant differ-
ences in demographic factors, cardiovascular sta-
tus on admission, coronary heart disease risk fac-
tors or MI localization in ECG between the groups.
All patients underwent primary PCI, and none had
a fibrinolytic therapy or receptor IIb/IIIa inhibitor
administered before hospital admission.
Course of the procedure
TFA was used in four patients in group I, three
presenting an abnormal Allen test, and the other
presenting an excessively tortuous radial artery
course with a bilateral loop, preventing the passage
of the catheter. One patient in group II underwent
the intervention via TRA, due to atherosclerosis
obliterans of the lower limbs. There was no differ-
ence in angiographic data (coronary heart disease
advancement, IRA, TIMI flow grade of the IRA)
between the groups (Table 2). PCI was attempted
in all the patients. PCI was not completed in one
patient from group II due to the impossibility of
balloon passage through the occluded area of the
artery. TIMI 3 flow was achieved in 88% of group I
patients and 92% of group II patients. The effective-
ness of heparin treatment was comparable in both
groups. Mean activated clotting time was 287.1 s
Figure 1. Flow chart of patients’ in-hospital course;
CABG — coronary artery bypass grafting.
335
Piotr Chodór et al., RADIAMI: A prospective, randomized, single-center clinical trial
www.cardiologyjournal.org
in both groups. Abciximab was administered to
a similar percentage of patients in both groups (44%
vs. 42%, groups I and II respectively). Stent place-
ment was performed in all the patients who under-
went PCI. There was no significant difference in the
amount of contrast media used, or in X-ray expo-
sure time between the groups.
Time intervals during percutaneous
coronary intervention
There were differences in initial time intervals
between the groups. The differences concerned the
time between the patient’s admission to hospital
and his or her arrival in the Cath Lab. This time was
longer in group I, but the difference was not statis-
tically significant. Significant differences appeared
for the following periods: from the admission to
hospital to the positioning of the vascular sheath,
to the first injection of contrast medium, to balloon
positioning and to stent implantation. These peri-
ods were significantly longer in group I compared
to group II, with the exception of the time to stent
implantation, which was at the border of significance.
The analysis of the intervals between the individual
stages of the procedure demonstrated that the differ-
ences were mostly due to the significant difference
in time from the arrival in the Cath Lab to vascular
sheath positioning and from sheath positioning to the
first contrast medium injection. These intervals were
significantly longer in group I. The other intervals (in-
jection–balloon, balloon–stent, stent–end of interven-
tion) did not differ significantly, similarly to the total
procedure time. Mean time interval from the end of
intervention to vascular sheath removal from the fem-
oral artery was 8.9 hours (Table 3).
Hospital observation
Mean time of patient mobilization (upright po-
sition) was significantly shorter in group I (20.18 ±
± 5.23 h) compared to group II (36.02 ± 33.55 h).
Mean hospitalization time was 6.26 ± 3.86 days in
group I vs. 6.75 ± 4.02 days in group II (p = 0.7727).
One patient belonging to group II deceased during
hospitalization due to left ventricular free wall rup-
ture. No patient necessitated an emergency CABG.
A repeated revascularization of the IRA had to be
performed in three patients (one in group I and two
in group II; one of the group I patients was diagnosed
Table 1. Basic clinical data of the patients.
Entire study Group I Group II P
group  (n = 50) (n = 50)
(n = 100) (transradial) (transfemoral)
Mean age (years) 59.5±9.1 59.9±9.4 59.1±9.0 NS
Height 169.1±8,4 167.8±7,5 169.5±9.2 NS
Body weight 82.2±14.7 79.5±11.7 85.0±16.8 NS
Men 68 (68%) 35 (51.5%) 33 (48.5%) NS
Diabetes 15 (15%) 8 (16%) 7 (14%) NS
Smoking 64 (64%) 34 (68%) 30 (60%) NS
Arterial hypertension 47 (47%) 26 (52%) 21 (42%) NS
Hyperlipidemia 19 (19%) 11 (22%) 8 (16%) NS
Past infarction 11 (11%) 8 (16%) 3 (6%) NS
Family history* 32 (32%) 16 (32%) 16 (32%) NS
Killip class 1 99 (99%) 50 (100%) 49 (98%) NS
Killip class 2 1 (1%) 0 (0%) 1 (2%) NS
MIN until admission [min] 291±282.6 247.7±159.9 337.26±362.4 NS**
HR at admission [beats/min] 78.2±15.0 78.3±13.7 78.2±16.4 NS
SBP at admission [mm Hg] 135.2±29.2 138.8±33.2 131.6±24.5 NS
DBP at admission [mm Hg] 78.4±17.9 80.1±18.6 76.7±17.1 NS
Infarction localization:
Anterior wall 42 (42%) 21 (42%) 21 (42%) NS
Inferior wall 54 (54%) 27 (54%) 27 (54%) NS
Left bundle branch block 0 (0%) 0 (0%) 0 (0%) NS
Other 4 (4%) 1 (4%) 2 (4%) NS
*Family history of coronary heart disease; **Mann-Whitney U test; MIN — mean infarction duration; DBP — diastolic blood pressure; SBP — systolic
blood pressure; HR — heart rate
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Table 3. Time intervals during coronary angiography and percutaneous coronary intervention.
Time from admission to (door to) Entire study Group I Group II P
group (n = 50) (n = 50)
 (n = 100)  (transradial)  (transfemoral)
Arrival in the Cath Lab [min] 35.7±21.6 37.8±21.0 33.7±22.2 NS
Sheath positioning [min] 49.1±22.9 53.7±21.9 44.4±23.1 0.04
First contrast injection [min] 56.0±25.1 62.3±25.5 50.2±23.8 0.02*
Balloon positioning [min] (door to balloon) 69.1±27.9 76.9±25.9 64.6±26.9 0.02*
Stent implantation [min] (door to stent) 77.9±27.2 83.2±26.3 72.3±27.3 0.05
End of intervention [min] 92.7±28.7 98.7±26.8 88.7±30.1 0.17
Arrival in the Cath Lab–sheath positioning time [min] 13.6±7.4 15.7±7.8 11.4±6.4 0.0028
Sheath–injection time [min] 6.6±6.4 8.6±7.8 4.5±3.3 0.0008*
Injection–balloon time [min] 15.1±7.9 15.6±8.7 14.6±7.1 NS
Balloon–stent time [min] 8.0±4.9 7.3±4.6 8.7±5.2 0.21
Stent–end of intervention time [min] 14.4±10.6 13.3±8.6 15.5±12.4 0.31
Procedure time [min] 56.8±18.1 58.3±17.8 55.1±18.4 0.38
Time from the end of intervention to sheath removal [h] 8.9±6.7
*Mann-Whitney U test
Table 2. Angiography data.
Entire study Group I (n = 50) Group II (n = 50) P
group (n = 100)   (transradial)  (transfemoral)
No. of pathologic vessels
1 36 (37.5%) 21 (42.9%) 15 (31.9%) NS
2 40 (41.7%) 19 (38.8%) 21 (44.7%) NS
3 20 (20.8%) 9 (18.4%) 11 (23.4%) NS
Infarct-related artery
LM 0 (0%) 0 (0%) 0 (0%) NS
LAD 43 (44.3%) 21 (42.9%) 22 (45.8%) NS
Cx 12 (12.4%) 9 (18.4%) 3 (6.2%) NS
RCA 42 (43.3%) 19 (38.8%) 23 (47.9%) NS
Initial TIMI flow grade:
0 53 (54.5%) 26 (53.1%) 27 (56.3%) NS
1 9 (9.3%) 5 (10.2%) 4 (8.3%) NS
2 19 (19.6%) 8 (16.3%) 11 (22.9%) NS
3 16 (16.5%) 10 (20.4%) 6 (12.5%) NS
Percutaneous coronary intervention 50 (100%) 50 (100%) 50 (100%) NS
Final TIMI flow grade:
0 1 (1%) 0 (0%) 1 (2%) NS
1 0 (0%) 0 (0%) 0 (0%) NS
2 9 (9%) 6 (12%) 3 (6%) NS
3 90 (90%) 44 (88%) 46 (92%) NS
Residual stenosis after 1.7±10.7 0.8±4.0 2.6±14.7 NS*
the intervention (%)
Mean max. ACT 287.1±84.5 280.0±94.5 294.4±73.5 NS*
Abciximab 43 (43%) 22 (44%) 21 (42%) NS
Exposure time [min] 11.1±6.3 10.9±5.6 11.2±7.0 NS
Contrast amount [mL] 198.7±45.7 198.7±45.7 197.7±72.0 NS*
No. of stents per patient 1.27±0.47 1.28±0.45 1.26±0.49 NS
Stenting percentage 99 (99%) 50 (100%) 49 (98%) NS
*Mann-Whitney U test; ACT — activated clotting time; LM — left mammary; LAD — left artery descending; Cx — circumflex artery;
RCA — right coronary artery; TIMI — Thrombolysis In Myocardial Infarction
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with a new myocardial infarction). Four patients in
group I and two in group II underwent PCI of a dif-
ferent artery than the IRA during their hospitaliza-
tion. Three patients in group II presented a major
bleeding necessitating a transfusion (gastrointesti-
nal hemorrhage in two cases, access site bleeding in
the other). One patient in group II developed an
ischemic stroke. There were no significant differenc-
es in hematocrit and hemoglobin values decrease and
hematoma prevalence between the groups (Table 4).
Doppler examination
An ultrasonography examination of femoral and
radial arteries was performed in all patients five
days after the intervention. An asymptomatic radi-
al artery occlusion was found in one patient in group
I. This was related to a longer than usual compres-
sion with a pressure dressing, due to repeated
bleeding. The ultrasonography examination found
a hematoma in one patient in group I (2%) and six
patients in group II (12%). No fistulas were found.
Discussion
Our study aimed to verify whether transradial
catheterization in patients with MI was as efficient
and safe as TFA. Literature data concerning this
problem is scarce. The randomized TEMPURA
study by Saito et al. [23] included 157 patients qua-
lified for transradial or transfemoral PCI, in whom
both access techniques were applicable. The TEM-
PURA study was conducted by investigators with
a lot of experience of performing procedures em-
ploying the TRA. Patients with Killip class III and
IV were also included in that study. No GP IIb/IIIa
receptor inhibitors were used. The subsequent
RADIAL-AMI study by Cantor et al. [26] included
50 patients with MI who underwent PCI with the
TRA (25 patients) or the TFA (25 patients). Throm-
bolysis was used in 66% of patients and GP IIb/IIIa
receptor inhibitors in 94%. That study also includ-
ed patients in whom both access sites were possi-
ble. Patients with cardiogenic shock and those with
contraindications to thrombolityc and/or GP IIb/IIIa
receptor inhibitors therapy were excluded from the
study. The study was conducted by operators who
had performed 100 interventions using the TRA.
Our study was conducted on a group of 100 patients
randomly included in the trial; the intention-to-treat
principle was applied. Abciximab was administered
in 43% of cases. Abciximab administration depend-
ed on the operator’s decision. The operator took
into consideration both the existing contraindica-
tions for Abciximab administration and TIMI flow
grade of the coronary artery in the initial angiogra-
phy. Stents were implanted in all the patients, apart
from one patient in group II in whom the interven-
tion was ineffective. TIMI 3 flow rate in the IRA was
Table 4. In-hospital course.
Entire study Group I Group II P
group  (n = 50) (n = 50)
(n = 100) (transradial) (transfemoral)
Mortality 1 (1%) 0 (0%) 1 (2%) NS
New infarction 1 (1%) 1 (2%) 0 (0%) NS
Stroke 1 (1%) 0 (0%) 1 (2%) NS
Composite death or myocardial infarction 2 (2%) 1 (2%) 1 (2%) NS
Composite death or stroke 3 (3%) 1 (2%) 2 (4%) NS
Repeated revascularization of 3 (3%) 1 (2%) 2 (4%) NS
the infarct-related artery
Aortocoronary by-pass grafting 0 (0%) 0 (0%) 0 (0%) NS
Interventions on other arteries performed 6 (6%) 4 (8%) 2 (4%) 0.4
during hospitalization
Major bleeding 10 (10%) 3 (6%) 7 (14%) 0.18
Fatal bleeding 0 (0%) 0 (0%) 0 (0%) NS
Requiring transfusion 3 (3%) 0 (0%) 3 (6%) 0.08
Requiring operation 0 (0%) 0 (0%) 0 (0%) NS
Drop in hemoglobin > 3 g/dL 7 (7%) 3 (6%) 4 (8%) NS
Intracranial hemorrhage 0 (0%) 0 (0%) 0 (0%) NS
Hematoma > 5 cm 13 (13%) 5 (10%) 8 (16%) 0.37
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obtained in 88% and 92% of patients (group I and II
respectively) and TIMI 2 flow rate in 12% and 6%
(group I and II respectively). The corresponding
procedure time was 58.3 min and 55.1 min, respec-
tively. In the Saito et al. study [23], TIMI 3 flow rate
was achieved in 96.1% and 97.2%, and TIMI 2 in
2.6% and 2.8% of patients (transradial and transfem-
oral group respectively); procedure time was 44 min
and 51 min, respectively [23]. It should be stressed
that both studies employed similar definitions of
procedural effectiveness and procedure time. Our
results are close to those obtained by Cantor et al.
[26]: they achieved TIMI 2/3 in 9%/87% and 12%/
/88% of patients (transradial and transfemoral group
respectively). They administered fibrynolytic drugs
in all the patients and GP IIb/IIIa receptor blockers
in a large part. X-ray exposure time in the present
study was comparable to that of Cantor et al. [26].
The weakness of PCI from radial approach is
that this procedure is considered to be technically
more difficult and requires a longer time to master.
In a case of myocardial infarction, it may prolong
the time from admission to balloon inflation. There
is a strong correlation between time from admis-
sion to balloon inflation and mortality rate. The long-
er the time, the higher the mortality rate [27, 28].
In our study it has been confirmed that the time
from admission to balloon inflation was longer in
group I than in group II and the difference was 12.3 m.
However, no impact attributable to this difference
on mortality rate in the investigated group was ob-
served. It may be ascribed to the small number of
patients and to the inclusion in this study of patients
with low primary death risk.
Moveover our analysis showed that total pro-
cedure time were comparable in both groups. The
observed differences in procedure times concerned
its initial stages. The times from the patient’s ar-
rival in the Cath Lab to the puncture, and from punc-
ture to first contract medium injection (first angi-
ography) were significantly longer in group I, which
is probably associated with less experience in em-
ploying the radial artery access site. However, ex-
tensive experience in the invasive treatment of MI
permitted the operators to achieve a comparable
total procedure time and X-ray exposure time,
which was even shorter in group I. The adminis-
tered amount of contrast media did not differ in both
groups. Cantor et al. [26] obtained similar results.
In their study, the delay in the procedure was most-
ly associated with the time difference from local
anesthesia to the first contrast medium injection
into the IRA. Several large non-interventional stud-
ies have established that performing examinations
from a radial approach is correlated with a lower rate
of major bleeding complications compared to per-
forming the same examinations from a femoral ap-
proach [13–15].
A lower bleeding complications rate corre-
sponds to lower mortality [16, 17]. Previous small
randomized studies in patients with myocardial in-
farction showed fewer complications in interven-
tions performed via the radial artery access site and
no significant differences [12, 19, 24]. In the TEM-
PURA study, bleeding complications were observed
only in the transfemoral group, but the difference
was not statistically significant (3% vs. 0%, p =
= 0.14). In that study no fibrynolytic or GP IIb/IIIa
receptor blocking drugs were used. Cantor et al.
[26] did not observe any major complications in the
transradial and the transfemoral groups. In the
present study, major bleeding complications oc-
curred in both groups (6% vs. 14% transradial and
transfemoral group respectively), but the difference
was not statistically significant (p = 0.18). In the
transradial group, major bleeding complications
were associated only with drop of haemoglobin
count of more than 3 g/dL; in the transfemoral group
these complications included transfusion and hae-
moglobin count drop. No difference in in-hospital
mortality was observed as there were no dissimi-
larities in bleeding complications. Major complica-
tions associated with artery puncturing are not more
prevalent in the TFA than in TRA, as has been pre-
viously suggested. This has been confirmed by ran-
domized studies, including the present work [23, 26].
It seems that a quick removal of the vascular
sheath from the femoral artery, the use of small
diameter sheaths, avoiding heparin administration
after the procedure when not essential, and ade-
quate heparinization during the procedure, mean
that the prevalence of major complications is as
small as in the TRA. The evaluation of other major
complications in the study population did not yield
statistically significant differences. One patient from
group II died five days after the intervention due to
left ventricular wall rupture, which raises the over-
all mortality rate to 1%. This is a low value; how-
ever, it should be noted that our study included
patients with a relatively good prognosis. The PAMI
study showed a mortality rate of 2.6% in patients
with invasive treatment and without shock [29].
Stent placement reduced the prevalence of new MI
and ischemia recurrence, as well as the necessity
for a repeated intervention. In the FRESCO study,
the prevalence of new MI was 1.3% and the preva-
lence of ischemia recurrence 3% [30]. In the present
study new MI occurred only in one patient (1%),
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and a repeated revascularization of the IRA was
performed in three (3%) patients (group I: 2%,
group II: 4%).
Our study demonstrates that patients who un-
dergo transradial catheterization are more quickly
rehabilitated and can faster assume the upright po-
sition. The difference in the upright position
achievement time was almost 15.8 hours. Group I
patients usually assumed the upright position dur-
ing the first 24 hours (20.18 h), while group II patients
usually did so only on the second day (36.02 h) after
the procedure. Because most patients belonged in-
itially to the low-risk group, a quick upright position
achievement was possible. The difference in the up-
right position achievement time was due to the need
for longer bed rest after the removal of the vascular
sheath from the femoral artery and the placement of
the dressing (a mean of 8.9 h after the end of the in-
tervention). Nevertheless, earlier upright position
achievement had no influence on the real time of hos-
pitalization, because in our center multiple additional
examinations (e.g. chest X-ray, echocardiography,
24-hour Holter monitoring) which are routinely per-
formed on the fifth day of hospitalization in all MI pa-
tients, prolong the total hospitalization time.
Limitations of the study
The conclusions from a single center study
cannot always be applied to other centers, as the
results depend on the operators’ experience. The
present study included a small number of patients.
Conclusions
TRA for PCI in patients with MI is equally ef-
fective as TFA. Total procedure time, X-ray expo-
sure time and the administered amount of contrast
media did not differ in either group. The differen-
ces in the times between the patient’s admission
and the individual stages of the PCI procedure were
mostly due to the longer intervals from the arrival
in the Cath Lab to vascular sheath positioning and
from sheath positioning to the first angiography in
the transradial group. TRA in PCI procedures in
patients with MI allows faster mobilization of the
patient. Complications are rare in both groups.
Acknowledgements
The authors do not report any conflict of inter-
est regarding this work.
References
1. Campeau L. Percutaneous radial artery approach for coronary
angiography. Cathet Cardiovasc Diagn, 1989; 16: 3–7.
2. Kimeneij F, Laarman GJ, Percutaneous transradial artery ap-
proach for coronary stent implantation. Cathet Cardiovasc
Diagn, 1993; 30: 173–178.
3. Schneider JE, Mann T, Cubeddu MG, Arrowood ME, Transradial
coronary stenting: A United States experience. J Invas Cardiol,
1997; 9: 569–574.
4. Grinfeld L, Berrocal D, Rojas Matas C, Magni J, Belardi J. What
is the most effective vascular approach for a diagnostic cardiac
catheterization? A randomized trial using the femoral, brachial
or radial approaches. J Am Coll Cardiol, 1996; 27 (suppl. A): 901
(abstract).
5. Saito S, Miyake S, Hosokawa G, Tanaka G, Kawamitsu K,
Kaneda H. Transradial coronary intervention in Japanese pa-
tients. Cathet Cardiovasc Intervent, 1999; 46: 37–41.
6. Wu CJ, Lo PH, Chang KC, Fu M, Lau KW, Hung JS. Transradial
coronary angiography and angioplasty in Chinese patients.
Cathet Cardiovasc Diagn, 1997; 40: 159–163.
7. Kiemeneij F, Laarman GJ, de Melker E. Transradial artery coro-
nary angioplasty. Am Heart J, 1995; 129: 1–7.
8. Kiemeneij F, Laarman GJ, Slagboon T, van der Wieken R. Out-
patient coronary stent implantation. J Am Coll Cardiol, 1997; 29:
323–327.
9. Gilchrist IC, Nickolaus MJ, Momplaisir T. Same-day transradial
outpatient stenting with a 6-hr course of glycoprotein IIb/IIIa
receptor blockade: A feasibility study. Cathet Cardiovasc Inter-
vent, 2002; 58: 10–13.
10. Hamon M, Sabatier R, Zhao Q, Niculescu R, Valette B, Grollier G.
Mini-invasive strategy in acute coronary syndromes: direct cor-
onary stenting using 5 Fr guiding catheters and transradial ap-
proach. Cathet Cardiovasc Intervent, 2002; 55: 340–343.
11. Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der
Wieken R. A randomized comparison of percutaneous translu-
minal coronary angioplasty by the radial, brachial and femoral
approaches: The Acces study. J Am Coll Cardiol, 1997; 29:
1269–1275.
12. Cruden NL, Teh CH, Starkey IR, Newby DE. Reduced vascular
complications and length of stay with transradial rescue angio-
plasty for acute myocardial infarction. Cathet Cardiovasc Inter-
vent, 2007;70: 670–675.
13. Hamon M, Mehta S, Steg G et al. Major bleeding in patients with
acute coronary syndrome undergoing early invasive manage-
ment can be reduced by fundaparinux, even in the context of
trans-radial coronary intervention: insights from OASIS-5 trial.
Circulation, 2006; 114 (suppl. II): 552.
14. Montalescot G, Ongen Z, Guindy R et al. Predictors of outcome
in patients undergoing PCI. Results of the RIVIERA study. Int J
Cardiol, 2007 [Epub ahead of print].
15. Chase AJ, Fretz EB, Warburton WP et al. Association of the
arterial access site at angioplasty with transfusion and mortality:
The MORTAL study (Mortality benefit Of Reduced Transfusion
after percutaneous coronary intervention via the Arm or Leg).
Heart, 2008; 94: 1019–1025.
340
Cardiology Journal 2009, Vol. 16, No. 4
www.cardiologyjournal.org
16. Feit F, Voeltz MD, Attubato MJ et al. Predictors and impact of
major hemorrhage on mortality following percutaneous coro-
nary intervention from the REPLACE-2 Trial. Am J Cardiol,
2007; 100: 1364–1369.
17. Rao SV, Ou F-S, Wang TY et al. Trends in the prevalence and
outcomes of radial and femoral approaches to percutaneous co-
ronary intervention. J Am Coll Cardiol Intv, 2008; 1: 1379–1386.
18. Louvard Y, Krol M, Pezzano M, Sheers L, Piechaud JF, Marien C.
Feasibility of routine transradial coronary angiography: A single
operator’s experience. J Invas Cardiol, 1999; 11: 543–548.
19. Hamon M, Mc Fadden E. Trans-radial approach for cardiovascu-
lar interventions. Europa Stethoscope Media 2003.
20. Louvard Y, Ludwig J, Lefevre T, Schmeisser A, Brück M,
Scheinert D. Transradial approach for coronary angioplasty in
the setting of acute myocardial infarction: A dual-center regis-
try. Cathet Cardiovasc Intervent, 2002; 55: 206–211.
21. Mulukutla SR, Cohen HA. Feasibility and efficacy of transradial
access for coronary interventions in patients with acute myo-
cardial infarction. Cathet Cardiovasc Intervent, 2002; 57: 167–
–171.
22. Kim MH, Cha KS, Kim HJ, Kim SG, Kim JS. Primary stenting
for acute myocardial infarction via transradial approach: A safe
and useful alternative to the transfemoral approach. J Invas Car-
diol, 2000; 12: 192–196.
23. Saito S, Tanaka SS, Hirpe Y, Miyashita Y, Takahashi S, Tanaka K.
Comparative study on transradial approach vs. transfemoral
approach in primary stent implantation for patients with acute
myocardial infarction: Results of the test for myocardial infarction
by prospective unicenter randomization for access site (TEMPURA)
trial. Cathet Cardiovasc Intervent, 2003; 59: 26–33.
24. Ochiai M, Isshiki T, Toyoizumi H, Eto K, Yokoyama N, Koyama Y.
Efficacy of transradial primary stenting in patients with acute
myocardial infarction. Am J Cardiol, 1999; 83: 966–968.
25. Sharma GL, Loubeyre C, Morice MC. Safety and feasibility of
the radial approach for primary angioplasty in acute myocardial
infarction during pregnancy. J Invas Cardiol, 2002; 14: 359–362.
26. Cantor WJ, Puley G, Natarajan MK, Dzavik V, Madan M, Fry A.
Radial versus femoral access for emergent percutaneous coro-
nary intervention with adjunct glycoprotein IIb/IIIa inhibition in
acute myocardial infarction: The RADIAL-AMI pilot randomized
trial. Am Heart J, 2005; 150: 543–549.
27. De Luca G, Suryapranata H, Zijstr F et al.; ZWOLLE Myocardial
Infarction Study Group. Symptoms-onest-to-ballon time and
mortality in patients with acute myocardial infarction treated by
primary angioblasty. J Am Coll Cardiol, 2003; 42: 991–997.
28. Nallamothu B, Fox KA, Kennelly BM et al. Relationship of treat-
ment delays and mortality in patients undergoing fibrinolysis
and primary percutaneous coronary intervention. The Global
Registry of Acute Coronary Events. Heart, 2007; 93: 1552–1555.
29. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D,
O’Keefe J. Predictors of in-hospital and 6-month outcome after
acute myocardial infarction in the reperfusion era: The Primary
Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll
Cardiol, 1995; 25: 370–377.
30. Antoniucci D, Santoro GM., Bolognese L, Valenti R, Trapani M,
Fazzini PF. A clinical trial comparing primary stenting of the
infarct-related artery with optimal primary angioplasty for acute
myocardial infarction: results from the Florence Randomized
Elective Stenting in Acute Coronary Occlusions (FRESCO) trial.
J Am Coll Cardiol, 1998; 31: 1234–1239.
